Two steroid-free immunosuppressive regimens (basiliximab/tacrolimus and tacrolimus/MMF) in comparison to tacrolimus/MMF/steroid therapy after renal transplantation

被引：0

作者：

Kramer, BK

Klinger, M

Salmela, K

Wlodarczyk, Z

Tyden, G

Vitko, S

机构：

[1] Univ Regensburg, D-8400 Regensburg, Germany

[2] Univ Wroclaw, PL-50138 Wroclaw, Poland

[3] Univ Helsinki, FIN-00014 Helsinki, Finland

[4] Poznan Hosp, Poznan, Poland

[5] Univ Stockholm, S-10691 Stockholm, Sweden

[6] Prague Agr Univ, Prague, Czech Republic

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9A / 9A

页数：1

共 50 条

[1] CHARACTERIZING STEROID-FREE REGIMENS POST LIVER TRANSPLANTATION: RANDOMIZED PHASE III TRIAL COMPARING TACROLIMUS MONOTHERAPY AFTER DACLIZUMAB INDUCTION AND TACROLIMUS plus MMF DUAL THERAPY
Cillo, U.
Otto, G.
Becker, T.
LIVER TRANSPLANTATION, 2009, 15 (07) : S96 - S96
[2] A prospective randomized trial comparing steroid-free immunosuppression induction with tacrolimus and MMF versus tacrolimus and steroids in patients with HCV
Mogl, MT
Neumann, UP
Langrehr, JM
Neuhaus, P
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 364 - 364
[3] First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV
Langrehr, JM
Neumann, UP
Lang, M
Müller, AR
Jonas, S
Settmacher, U
Steinmüller, T
Neuhaus, P
TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1565 - 1566
[4] FEASIBILITY OF STEROID-FREE TACROLIMUS-BASILIXIMAB IMMUNOSUPPRESSION IN PEDIATRIC LIVER TRANSPLANTATION
Riva, Natalia
Trezeguet Renatti, Guido
Meza, Veronica
Gole, Maria
Reijenstein, Hayellen
Gonzalez, Valeria
Minetto, Julia
Licciardone, Nieves
Dip, Marcelo
Schaiquevich, Paula
Halac, Esteban
Imventarza, Oscar C.
TRANSPLANTATION, 2020, 104 (09) : S628 - S628
[5] Patient Outcomes in Two Steroid-Free Regimens Using Tacrolimus Monotherapy After Daclizumab Induction and Tacrolimus With Mycophenolate Mofetil in Liver Transplantation
Becker, Thomas
Foltys, Daniel
Bilbao, Itxarone
D'Amico, Davide
Colledan, Michele
Bernardos, Angel
Beckebaum, Susanne
Isoniemi, Helena
Pirenne, Jacques
Jaray, Jenoe
TRANSPLANTATION, 2008, 86 (12) : 1689 - 1694
[6] Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe
Loucaidou, M
Borrows, R
Cairns, T
Griffith, M
Hakim, N
Palmer, A
Papalois, V
Taube, D
McLean, AG
TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1795 - 1796
[7] Feasibility of steroid-free tacrolimus-basiliximab immunosuppression in pediatric liver transplantation and predictors for steroid requirement
Renatti, Guido Trezeguet
Riva, Natalia
Minetto, Julia
Reijenstein, Hayellen
Gole, Maria
Meza, Veronica
Bosaleh, Andrea
Licciardone, Nieves
Aredes, Diego
Lauferman, Leandro
Cervio, Guillermo
Dip, Marcelo
Schaiquevich, Paula
Halac, Esteban
Imventarza, Oscar
LIVER TRANSPLANTATION, 2024, 30 (01) : 61 - 71
[8] THE INCIDENCE OF ACUTE ANTIBODY MEDIATED KIDNEY TRANSPLANT REJECTION UNDER MODERN IMMUNOSUPPRESSION: COMPARISON OF TACROLIMUS MONOTHERAPY WITH TACROLIMUS/MMF STEROID-FREE MAINTENANCE REGIMES
Willicombe, Michelle
Taube, David H.
Galliford, Jack
Brookes, Paul
McLean, Adam G.
TRANSPLANT INTERNATIONAL, 2011, 24 : 37 - 37
[9] Steroid avoidance with tacrolimus and MMF in low and medium risk renal transplants.
Cherukuri, Aravind
Border, David
Tibble, Stephen
Ahmad, Niaz
Menon, Krish
Newstead, Chas
Lewington, Andrew
Baker, Richard
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 452 - 452
[10] SAFETY AND EFFICACY OF STEROID-FREE IMMUNOSUPPRESSION POST-LIVER TRANSPLANTATION: A RANDOMISED PHASE III TRIAL COMPARING TACROLIMUS MONOTHERAPY AFTER DACLIZUMAB INDUCTION VERSUS TACROLIMUS plus MMF DUAL THERAPY
Bilbao, I.
Otto, G.
Becker, T.
D'Amico, D.
Colledan, M.
Bernardos, A.
Beckebaum, S.
Isoniemi, H.
Pirenne, J.
Jaray, J.
JOURNAL OF HEPATOLOGY, 2009, 50 : S58 - S59

← 1 2 3 4 5 →